SCHEMBL3680288

SCHEMBL3680288

N#CC(=NO)c1ccc(F)cc1F

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.47
CES1 P23141 3/20 0.47
ALDH1A1 P00352 2/20 0.41
HTT P42858 2/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
KCNH2 Q12809 1/20 0.36
POLB P06746 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
CA3 P07451 1/20 0.33
CA6 P23280 1/20 0.33
CA5A P35218 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33
CA5B Q9Y2D0 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3680287 1.00 CES2 (0.47) CES2CES1ALDH1A1HTTLMNA
SCHEMBL3680330 0.85 CES2 (0.47) CES2CES1ALDH1A1HTTLMNA
SCHEMBL3680333 0.85 CES2 (0.47) CES2CES1ALDH1A1HTTLMNA
SCHEMBL9823228 0.82 HPGD (0.40) ALDH1A1HTTLMNAMAPTPOLB
SCHEMBL10472439 0.81 HPGD (0.39) ALDH1A1HTTLMNAMAPTKMT2A
SCHEMBL10472437 0.81 HPGD (0.39) ALDH1A1HTTLMNAMAPTPOLB
SCHEMBL10753337 0.77 CES2 (0.43) CES2CES1ALDH1A1HTTLMNA
SCHEMBL10753333 0.77 CES2 (0.43) CES2CES1ALDH1A1HTTLMNA
SCHEMBL24445679 0.75 CES2 (0.52) CES2CES1ALDH1A1MAPTPOLB
SCHEMBL10752112 0.72 LMNA (0.53) CES2CES1ALDH1A1HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7727967-B2 Cyanooxime inhibitors of carbonyl reductase and methods of using said inhibitors in treatments involving anthracyclines BOISE STATE UNIVERSITY (US) 2010-06-01 US claimed
US-20080182804-A1 CYANOOXIME INHIBITORS OF CARBONYL REDUCTASE AND METHODS OF USING SAID INHIBITORS IN TREATMENTS INVOLVING ANTHRACYCLINES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-07-31 US claimed
US-7781412-B2 Biphenyl inhibitors of carbonyl reductase BOISE STATE UNIVERSITY (US) 2010-08-24 US disclosed
US-7727967-B2 Cyanooxime inhibitors of carbonyl reductase and methods of using said inhibitors in treatments involving anthracyclines BOISE STATE UNIVERSITY (US) 2010-06-01 US disclosed
WO-2009048760-A2 BIPHENYL INHIBITORS OF CARBONYL REDUCTASE BOISE STATE UNIVERSITY (US) 2009-04-16 WO disclosed
US-20080227731-A1 BIPHENYL INHIBITORS OF CARBONYL REDUCTASE BOISE STATE UNIVERSITY (US) 2008-09-18 US disclosed
US-20080182804-A1 CYANOOXIME INHIBITORS OF CARBONYL REDUCTASE AND METHODS OF USING SAID INHIBITORS IN TREATMENTS INVOLVING ANTHRACYCLINES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-07-31 US disclosed
US-20080182804-A1 CYANOOXIME INHIBITORS OF CARBONYL REDUCTASE AND METHODS OF USING SAID INHIBITORS IN TREATMENTS INVOLVING ANTHRACYCLINES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-07-31 US disclosed